Product NewsDrug discovery > Clinical Development ISA Pharmaceuticals Presents Novel Data at the European Cancer Congress 2013: Strong Synergies Between Cancer Vaccine ISA101 and Chemotherapy
Product NewsDrug discovery > Clinical Development ISA Pharmaceuticals Initiates Phase I/II Clinical Trial of ISA101 in Patients with Anal Intraepithelial Neoplasia (AIN)
Product NewsClinical Diagnostics Genticel Secures EUR 18.2 million (USD 23.7 million) in Capital Funding to Develop Vaccines for Patients Infected with HPV